Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Sprague

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Expert Review of Endocrinology & Metabolism|July 31, 2018
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney diseaseStuart M Sprague, Stephen A Strugnell, Charles W Bishop
Journal of Tissue Engineering and Regenerative Medicine|August 14, 2012
Impact of serum source and inflammatory cytokines on the isolation of endothelial colony-forming cells from peripheral bloodKaren A Lapidos, Stuart M Sprague, Guillermo A Ameer
American Journal of Nephrology|September 13, 2021
Small Intestinal Phosphate Absorption: Novel Therapeutic ImplicationsJerry Yee, David Rosenbaum, Jeffrey W Jacobs, et al.
Seminars in Dialysis|April 7, 2017
Imaging in Chronic Kidney Disease-Metabolic Bone DiseaseAnup J Alexander, David Jahangir, Martin Lazarus, et al.
Kidney International|March 13, 2003
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidismStuart M Sprague, Francisco Llach, Michael Amdahl, et al.
American Journal of Nephrology|January 12, 2007
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney diseaseAnna L Zisman, Marta Hristova, L Tammy Ho, et al.
Journal of Nephrology|March 5, 2015
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too lowJennifer L Ennis, Elaine M Worcester, Fredric L Coe, et al.
American Journal of Nephrology|November 12, 2005
Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferolAnna L Zisman, Walid Ghantous, Pamela Schinleber, et al.
Blood Purification|June 9, 2005
Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from bloodCynthia M Daniels, Emily M Woolverton, Stuart M Sprague, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKDDaniel W Coyne, Seth Goldberg, Mark Faber, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Expert Review of Endocrinology & Metabolism|July 31, 2018
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney diseaseStuart M Sprague, Stephen A Strugnell, Charles W Bishop
Journal of Tissue Engineering and Regenerative Medicine|August 14, 2012
Impact of serum source and inflammatory cytokines on the isolation of endothelial colony-forming cells from peripheral bloodKaren A Lapidos, Stuart M Sprague, Guillermo A Ameer
American Journal of Nephrology|September 13, 2021
Small Intestinal Phosphate Absorption: Novel Therapeutic ImplicationsJerry Yee, David Rosenbaum, Jeffrey W Jacobs, et al.
Seminars in Dialysis|April 7, 2017
Imaging in Chronic Kidney Disease-Metabolic Bone DiseaseAnup J Alexander, David Jahangir, Martin Lazarus, et al.
Kidney International|March 13, 2003
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidismStuart M Sprague, Francisco Llach, Michael Amdahl, et al.
American Journal of Nephrology|January 12, 2007
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney diseaseAnna L Zisman, Marta Hristova, L Tammy Ho, et al.
Journal of Nephrology|March 5, 2015
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too lowJennifer L Ennis, Elaine M Worcester, Fredric L Coe, et al.
American Journal of Nephrology|November 12, 2005
Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferolAnna L Zisman, Walid Ghantous, Pamela Schinleber, et al.
Blood Purification|June 9, 2005
Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from bloodCynthia M Daniels, Emily M Woolverton, Stuart M Sprague, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKDDaniel W Coyne, Seth Goldberg, Mark Faber, et al.
Pageof 12